EUVIMEDEUVIMED entdecken
Übersichtsarbeit

From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro , Ex Vivo , and In Vivo Studies

Cinzia Cimino, Lorena Bonilla Vidal, Federica Conti, Elena Sánchez López, Claudio Bucolo, Maria Luisa García, Teresa Musumeci, Rosario Pignatello iD, Claudia Carbone

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00725 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Cinzia Cimino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Delivery Technology, Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95124 Catania, Italy. Hauptthemen laut MEDLINE: Nanoparticles, Drug Delivery Systems, Administration, Ophthalmic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 340 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of ocular pathologies is constantly increasing, as is the interest of the researchers in developing new strategies to ameliorate the treatment of these conditions. Nowadays, drug delivery systems are considered among the most relevant approaches due to their applicability in the treatment of a great variety of inner and outer eye pathologies through painless topical administrations. The design of such nanocarriers requires a deep study of many aspects related to the administration route but also a consideration of the authorities and pharmacopeial requirements, in order to achieve a clinical outcome. On such bases, the scope of this review is to describe the path of the analyses that could be performed on nanoparticles, along with the assessment of their applicability for ophthalmic treatments. Preformulation studies, physicochemical and technological characterization, and preliminary noncellular in vitro studies have been described in part 1 of this review. Herein, first the in vitro cellular assays are described; subsequently, nonocular organotypic tests and ex vivo studies are reported, as to present the various analyses to which the formulations can be subjected before in vivo studies, described in the last part. In each step, the models that could be used are presented and compared, highlighting the pros and cons. Moreover, their reliability and eventual acceptance by regulatory agencies are discussed. Hence, this review provides an overview of the most relevant assays applicable for nanocarriers intended for ophthalmic administration to guide researchers in the experimental decision process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesDrug Delivery SystemsAdministration, OphthalmicHumansAnimalsDrug CarriersEye DiseasesEye

Stichwörter der Autor:innen

animal studiescell assayslipid nanoparticlesocular requisitespolymeric nanoparticlestopical delivery

Substanzen

Drug Carriers

Autor:innen und Institutionen

  • Laboratory of Drug Delivery Technology, Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95124 Catania, Italy.
  • NANOMED, Research Centre for Nanomedicine and Pharmaceutical Nanotechnology, University of Catania, 95124 Catania, Italy.
  • Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.
  • Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
  • Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95124 Catania, Italy.
  • Unit of Synthesis and Biomedical Applications of Peptides, IQAC-CSIC, 08034 Barcelona, Spain.

ORCID-Profile: Rosario Pignatello

Zitieren

APA

Cimino, C., Vidal, L. B., Conti, F., López, E. S., Bucolo, C., García, M. L., Musumeci, T., Pignatello, R., & Carbone, C. (2024). From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro , Ex Vivo , and In Vivo Studies. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00725

Vancouver

Cimino C, Vidal LB, Conti F, López ES, Bucolo C, García ML, et al. From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro , Ex Vivo , and In Vivo Studies. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00725

BibTeX
@article{Cimino2024,
  author = {Cimino, Cinzia and Vidal, Lorena Bonilla and Conti, Federica and López, Elena Sánchez and Bucolo, Claudio and García, Maria Luisa and Musumeci, Teresa and Pignatello, Rosario and Carbone, Claudia},
  title = {From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro , Ex Vivo , and In Vivo Studies},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00725}
}
Kostenlos starten →